Lacavir-ET Tablet
By Lacavir-ET
Rx
30 Tablet in a Bottle

Composition
Lamivudine(300mg) + Tenofovir disoproxil fumarate(300mg) + Efavirenz(600mg)

Manufacturer - Care Formulation Labs Pvt Ltd
D-1659, DSIIDC, Narela Industrial Area, Delhi, 110040

Expires on or after
October, 2025

liver
Safety Advice - Liver When it comes to using Lacavir-ET Tablet, it is believed to be generally safe for individuals with liver disease based on the limited available data. There is no significant evidence to suggest that dose adjustment is necessary in these patients. However, it is strongly advised to inform your doctor about any history of liver diseases before starting Lacavir-ET Tablet 30'S, as dose adjustment may be necessary in some cases. It is always best to consult with your doctor to ensure your safety and well-being when considering the use of Lacavir-ET Tablet.

kidney
Limited data suggests that Lacavir-ET Tablet is likely safe for use in patients with kidney disease. However, it is recommended to inform your doctor about any history of kidney diseases before taking the medication, as dose adjustment may be necessary. Please consult your doctor for proper guidance before using Lacavir-ET Tablet.

alcohol
When taking Lacavir-ET Tablet, it's important to avoid alcohol consumption, as it can raise the risk of liver damage. Consult your doctor before drinking alcohol with this medication.

driving
When taking Lacavir-ET Tablet, be cautious as it can reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if you experience any of these symptoms to ensure safety on the road.

pregnancy
Lacavir-ET Tablet is not safe for use during pregnancy due to potential risks to the developing baby. Consult your doctor before using, especially if you are pregnant or planning to conceive. In rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks.

breastfeeding
Lacavir-ET Tablet appears safe for breastfeeding based on limited data. However, Lacavir-ET Tablet 30'S is not recommended as it excretes into breast milk. Consult a doctor before use during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹2900
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024